TCIM
IMGN

TIAA CREF Investment Management’s Immunogen Inc IMGN Stock Holding History

TIAA CREF Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$783K Sell
289,113
-280,205
-49% -$1.21M ﹤0.01% 2424
2018
Q4 		$2.73M Sell
569,318
-633,634
-53% -$3.84M ﹤0.01% 1766
2018
Q3 		$11.4M Buy
1,202,952
+7,316
+0.6% +$70.3K 0.01% 1035
2018
Q2 		$11.6M Buy
1,195,636
+554,810
+87% +$5.85M 0.01% 1064
2018
Q1 		$6.74M Sell
640,826
-79,397
-11% -$784K ﹤0.01% 1368
2017
Q4 		$4.62M Buy
720,223
+16,331
+2% +$101K ﹤0.01% 1648
2017
Q3 		$5.38M Buy
703,892
+451,632
+179% +$3M ﹤0.01% 1572
2017
Q2 		$1.79M Buy
252,260
+7,658
+3% +$35K ﹤0.01% 2242
2017
Q1 		$947K Sell
244,602
-18,366
-7% -$53.6K ﹤0.01% 2534
2016
Q4 		$536K Sell
262,968
-26,074
-9% -$52.3K ﹤0.01% 2814
2016
Q3 		$775 Sell
289,042
-6,534
-2% -$19K ﹤0.01% 2662
2016
Q2 		$910K Sell
295,576
-6,069
-2% -$38.1K ﹤0.01% 2564
2016
Q1 		$2.57M Hold
301,645
– – ﹤0.01% 1935
2015
Q4 		$4.09M Sell
301,645
-10,627
-3% -$131K ﹤0.01% 1700
2015
Q3 		$3M Sell
312,272
-19,468
-6% -$285K ﹤0.01% 1894
2015
Q2 		$4.77M Buy
331,740
+5,536
+2% +$60.8K ﹤0.01% 1714
2015
Q1 		$2.92M Buy
326,204
+20,989
+7% +$152K ﹤0.01% 1983
2014
Q4 		$1.86M Sell
305,215
-29,620
-9% -$271K ﹤0.01% 2297
2014
Q3 		$3.55M Sell
334,835
-25,655
-7% -$290K ﹤0.01% 1851
2014
Q2 		$4.27M Buy
360,490
+14,462
+4% +$182K ﹤0.01% 1801
2014
Q1 		$5.17M Sell
346,028
-4,950
-1% -$78K ﹤0.01% 1581
2013
Q4 		$5.15M Sell
350,978
-7,337
-2% -$113K ﹤0.01% 1622
2013
Q3 		$6.1M Sell
358,315
-8,437
-2% -$148K ﹤0.01% 1433
2013
Q2 		$6.08M Buy
+366,752
New +$5.94M 0.01% 1386

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TIAA CREF Investment Management's IMGN Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Immunogen Inc (IMGN) stake by 49% in Q1 2019, selling an estimated $1.21M and leaving 289,113 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

TIAA CREF Investment Management first reported a position in IMGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $11.6M in Q2 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

  • TIAA CREF Investment Management held 289,113 shares of Immunogen Inc worth $783K as of Q1 2019.
  • TIAA CREF Investment Management sold 280,205 Immunogen Inc shares in Q1 2019, an estimated $1.21M.
  • Immunogen Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2424 holding.
  • TIAA CREF Investment Management first reported a position in Immunogen Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Immunogen Inc position peaked at $11.6M in Q2 2018.
  • 212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.